Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Interactions between Alcohol Consumption and Adjuvant Hormone Therapy in Relation to Breast Cancer-Free Survival.

Kowalski A, Striley CW, Varma DS, Egan KM, Yaghjyan L.

J Breast Cancer. 2018 Jun;21(2):158-164. doi: 10.4048/jbc.2018.21.2.158. Epub 2018 Jun 20.

2.

Height, waist circumference, body mass index, and body somatotype across the life course and risk of glioma.

Cote DJ, Downer MK, Smith TR, Smith-Warner SA, Egan KM, Stampfer MJ.

Cancer Causes Control. 2018 Aug;29(8):707-719. doi: 10.1007/s10552-018-1052-x. Epub 2018 Jun 26.

PMID:
29943102
3.

Toenail selenium, genetic variation in selenoenzymes and risk and outcome in glioma.

Peeri NC, Creed JH, Anic GM, Thompson RC, Olson JJ, LaRocca RV, Chowdhary SA, Brockman JD, Gerke TA, Nabors LB, Egan KM.

Cancer Epidemiol. 2018 Aug;55:45-51. doi: 10.1016/j.canep.2018.05.002. Epub 2018 May 25.

PMID:
29777993
4.

Interactions of coffee consumption and postmenopausal hormone use in relation to breast cancer risk in UK Biobank.

Yaghjyan L, Rich S, Mao L, Mai V, Egan KM.

Cancer Causes Control. 2018 Jun;29(6):519-525. doi: 10.1007/s10552-018-1028-x. Epub 2018 Apr 12.

PMID:
29651651
5.

Handedness and the risk of glioma.

Miller B, Peeri NC, Nabors LB, Creed JH, Thompson ZJ, Rozmeski CM, LaRocca RV, Chowdhary S, Olson JJ, Thompson RC, Egan KM.

J Neurooncol. 2018 May;137(3):639-644. doi: 10.1007/s11060-018-2759-y. Epub 2018 Jan 13.

PMID:
29332185
6.

Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.

Poff A, Koutnik AP, Egan KM, Sahebjam S, D'Agostino D, Kumar NB.

Semin Cancer Biol. 2017 Dec 30. pii: S1044-579X(17)30124-4. doi: 10.1016/j.semcancer.2017.12.011. [Epub ahead of print] Review.

PMID:
29294371
7.

Emerging Trends in Family History of Breast Cancer and Associated Risk.

Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, Kerlikowske K, Braithwaite D, Buist DSM, Egan KM, Newcomb PA, Trentham-Dietz A.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1753-1760. doi: 10.1158/1055-9965.EPI-17-0531. Epub 2017 Oct 6.

8.

Erratum to: Older age at the completion of linear growth is associated with an increased risk of adult glioma.

Little RB, Burt Nabors L, Olson JJ, Thompson ZJ, Rozmeski CM, LaRocca RV, Forsyth PA, Thompson RC, Oster RA, Chowdhary SA, Egan KM.

Cancer Causes Control. 2017 Jul;28(7):717-718. doi: 10.1007/s10552-017-0893-z. No abstract available.

PMID:
28455551
9.

Older age at the completion of linear growth is associated with an increased risk of adult glioma.

Little RB, Nabors LB, Olson JJ, Thompson ZJ, Rozmeski CM, LaRocca RV, Forsyth PA, Thompson RC, Oster RA, Chowdhary SA, Egan KM.

Cancer Causes Control. 2017 Jul;28(7):709-716. doi: 10.1007/s10552-017-0871-5. Epub 2017 Mar 4. Erratum in: Cancer Causes Control. 2017 Jul;28(7):717-718.

10.

Abrupt Onset of Ulcerative Papules and Nodules on the Face and Genitals.

Payne LC, Egan KM, Aziz N.

JAMA Dermatol. 2016 Jul 1;152(7):829-30. doi: 10.1001/jamadermatol.2016.0017. No abstract available.

PMID:
26933833
11.

Analgesic use and the risk of primary adult brain tumor.

Egan KM, Nabors LB, Thompson ZJ, Rozmeski CM, Anic GA, Olson JJ, LaRocca RV, Chowdhary SA, Forsyth PA, Thompson RC.

Eur J Epidemiol. 2016 Sep;31(9):917-25. doi: 10.1007/s10654-016-0129-7. Epub 2016 Feb 19.

12.

Cigarette Smoking Before and After Breast Cancer Diagnosis: Mortality From Breast Cancer and Smoking-Related Diseases.

Passarelli MN, Newcomb PA, Hampton JM, Trentham-Dietz A, Titus LJ, Egan KM, Baron JA, Willett WC.

J Clin Oncol. 2016 Apr 20;34(12):1315-22. doi: 10.1200/JCO.2015.63.9328. Epub 2016 Jan 25.

13.

Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy.

Doepker MP, Thompson ZJ, Harb JN, Messina JL, Puleo CA, Egan KM, Sarnaik AA, Gonzalez RJ, Sondak VK, Zager JS.

J Surg Oncol. 2016 Jan;113(1):98-102. doi: 10.1002/jso.24088. Epub 2015 Dec 10.

14.

Complementary therapy and survival in glioblastoma.

Mulpur BH, Nabors LB, Thompson RC, Olson JJ, LaRocca RV, Thompson Z, Egan KM.

Neurooncol Pract. 2015 Sep;2(3):122-126. Epub 2015 May 6.

15.

Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility.

Baskin R, Woods NT, Mendoza-Fandiño G, Forsyth P, Egan KM, Monteiro AN.

Sci Rep. 2015 Nov 27;5:17367. doi: 10.1038/srep17367.

16.

Increased vitamin D and calcium intake associated with reduced mammographic breast density among premenopausal women.

Fair AM, Lewis TJ, Sanderson M, Dupont WD, Fletcher S, Egan KM, Disher AC.

Nutr Res. 2015 Oct;35(10):851-857. doi: 10.1016/j.nutres.2015.07.004. Epub 2015 Jul 31.

17.

Variation in Breast Cancer-Risk Factor Associations by Method of Detection: Results From a Series of Case-Control Studies.

Sprague BL, Gangnon RE, Hampton JM, Egan KM, Titus LJ, Kerlikowske K, Remington PL, Newcomb PA, Trentham-Dietz A.

Am J Epidemiol. 2015 Jun 15;181(12):956-69. doi: 10.1093/aje/kwu474. Epub 2015 May 5.

18.

Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.

Kumar NB, Pow-Sang J, Egan KM, Spiess PE, Dickinson S, Salup R, Helal M, McLarty J, Williams CR, Schreiber F, Parnes HL, Sebti S, Kazi A, Kang L, Quinn G, Smith T, Yue B, Diaz K, Chornokur G, Crocker T, Schell MJ.

Cancer Prev Res (Phila). 2015 Oct;8(10):879-87. doi: 10.1158/1940-6207.CAPR-14-0324. Epub 2015 Apr 14.

19.

Prediction of breast cancer risk based on profiling with common genetic variants.

Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q, Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Czene K, Darabi H, Eriksson M, Peto J, Dos-Santos-Silva I, Dudbridge F, Johnson N, Schmidt MK, Broeks A, Verhoef S, Rutgers EJ, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, Figueroa J, Chanock SJ, Brinton L, Lissowska J, Couch FJ, Olson JE, Vachon C, Pankratz VS, Lambrechts D, Wildiers H, Van Ongeval C, van Limbergen E, Kristensen V, Grenaker Alnæs G, Nord S, Borresen-Dale AL, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Trentham-Dietz A, Newcomb P, Titus L, Egan KM, Hunter DJ, Lindstrom S, Tamimi RM, Kraft P, Rahman N, Turnbull C, Renwick A, Seal S, Li J, Liu J, Humphreys K, Benitez J, Pilar Zamora M, Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Bogdanova NV, Antonenkova NN, Dörk T, Anton-Culver H, Neuhausen SL, Ziogas A, Bernstein L, Devilee P, Tollenaar RA, Seynaeve C, van Asperen CJ, Cox A, Cross SS, Reed MW, Khusnutdinova E, Bermisheva M, Prokofyeva D, Takhirova Z, Meindl A, Schmutzler RK, Sutter C, Yang R, Schürmann P, Bremer M, Christiansen H, Park-Simon TW, Hillemanns P, Guénel P, Truong T, Menegaux F, Sanchez M, Radice P, Peterlongo P, Manoukian S, Pensotti V, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Brauch H, Brüning T, Ko YD, Sigurdson AJ, Doody MM, Hamann U, Torres D, Ulmer HU, Försti A, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Andrulis IL, Knight JA, Glendon G, Marie Mulligan A, Chenevix-Trench G, Balleine R, Giles GG, Milne RL, McLean C, Lindblom A, Margolin S, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Eilber U, Wang-Gohrke S, Hooning MJ, Hollestelle A, van den Ouweland AM, Koppert LB, Carpenter J, Clarke C, Scott R, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Brenner H, Arndt V, Stegmaier C, Karina Dieffenbach A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Offit K, Vijai J, Robson M, Rau-Murthy R, Dwek M, Swann R, Annie Perkins K, Goldberg MS, Labrèche F, Dumont M, Eccles DM, Tapper WJ, Rafiq S, John EM, Whittemore AS, Slager S, Yannoukakos D, Toland AE, Yao S, Zheng W, Halverson SL, González-Neira A, Pita G, Rosario Alonso M, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, Simard J, Hall P, Easton DF, Garcia-Closas M.

J Natl Cancer Inst. 2015 Apr 8;107(5). pii: djv036. doi: 10.1093/jnci/djv036. Print 2015 May.

20.

Birth desires and intentions of women diagnosed with a meningioma.

Owens MA, Craig BM, Egan KM, Reed DR.

J Neurosurg. 2015 May;122(5):1151-6. doi: 10.3171/2014.11.JNS14522. Epub 2015 Jan 27.

21.

Alcohol consumption and prevalence of human papillomavirus (HPV) infection among US men in the HPV in Men (HIM) study.

Schabath MB, Thompson ZJ, Egan KM, Torres BN, Nguyen A, Papenfuss MR, Abrahamsen ME, Giuliano AR.

Sex Transm Infect. 2015 Feb;91(1):61-7. doi: 10.1136/sextrans-2013-051422. Epub 2014 Oct 2.

22.

Reproductive windows, genetic loci, and breast cancer risk.

Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, Engelman CD, Klein BE, Titus LJ, Egan KM, Newcomb PA.

Ann Epidemiol. 2014 May;24(5):376-82. doi: 10.1016/j.annepidem.2014.02.007. Epub 2014 Mar 2.

23.

Brain tumor risk according to germ-line variation in the MLLT10 locus.

Egan KM, Baskin R, Nabors LB, Thompson RC, Olson JJ, Browning JE, Madden MH, Monteiro AN.

Eur J Hum Genet. 2015 Jan;23(1):132-4. doi: 10.1038/ejhg.2014.70. Epub 2014 Apr 23.

24.

What is your diagnosis? Recurrent lobular capillary hemangioma with satellitosis (Warner and Wilson-Jones syndrome).

Ballin JS, Egan KM, Satter EK.

Cutis. 2014 Mar;93(3):125, 132-3. No abstract available.

PMID:
24738100
25.

Reproductive factors and risk of primary brain tumors in women.

Anic GM, Madden MH, Nabors LB, Olson JJ, LaRocca RV, Thompson ZJ, Pamnani SJ, Forsyth PA, Thompson RC, Egan KM.

J Neurooncol. 2014 Jun;118(2):297-304. doi: 10.1007/s11060-014-1427-0. Epub 2014 Apr 4.

26.

Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care.

van de Water W, Bastiaannet E, Egan KM, de Craen AJ, Westendorp RG, Balducci L, van de Velde CJ, Liefers GJ, Extermann M.

J Geriatr Oncol. 2014 Jul;5(3):252-9. doi: 10.1016/j.jgo.2014.02.005. Epub 2014 Mar 21.

27.

Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies.

Trentham-Dietz A, Sprague BL, Hampton JM, Miglioretti DL, Nelson HD, Titus LJ, Egan KM, Remington PL, Newcomb PA.

Breast Cancer Res Treat. 2014 May;145(1):165-75. doi: 10.1007/s10549-014-2905-y. Epub 2014 Mar 20.

28.

Current approaches to the treatment of metastatic brain tumours.

Owonikoko TK, Arbiser J, Zelnak A, Shu HK, Shim H, Robin AM, Kalkanis SN, Whitsett TG, Salhia B, Tran NL, Ryken T, Moore MK, Egan KM, Olson JJ.

Nat Rev Clin Oncol. 2014 Apr;11(4):203-22. doi: 10.1038/nrclinonc.2014.25. Epub 2014 Feb 25. Review.

29.

Inherited variation in the PARP1 gene and survival from melanoma.

Davies JR, Jewell R, Affleck P, Anic GM, Randerson-Moor J, Ozola A, Egan KM, Elliott F, García-Casado Z, Hansson J, Harland M, Höiom V, Jian G, Jönsson G, Kumar R, Nagore E, Wendt J, Olsson H, Park JY, Patel P, Pjanova D, Puig S, Schadendorf D, Sivaramakrishna Rachakonda P, Snowden H, Stratigos AJ, Bafaloukos D, Ogbah Z, Sucker A, Van den Oord JJ, Van Doorn R, Walker C, Okamoto I, Wolter P, Barrett JH, Timothy Bishop D, Newton-Bishop J.

Int J Cancer. 2014 Oct 1;135(7):1625-33. doi: 10.1002/ijc.28796. Epub 2014 Mar 6.

30.

Breast cancer susceptibility loci in association with age at menarche, age at natural menopause and the reproductive lifespan.

Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Skinner HG, Engelman CD, Klein BE, Titus LJ, Egan KM, Newcomb PA.

Cancer Epidemiol. 2014 Feb;38(1):62-5. doi: 10.1016/j.canep.2013.12.001. Epub 2013 Dec 25.

31.

An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study.

Davies JR, Field S, Randerson-Moor J, Harland M, Kumar R, Anic GM, Nagore E, Hansson J, Höiom V, Jönsson G, Gruis NA, Park JY, Guan J, Sivaramakrishna Rachakonda P, Wendt J, Pjanova D, Puig S, Schadendorf D, Okamoto I, Olsson H, Affleck P, García-Casado Z, Puig-Butille JA, Stratigos AJ, Kodela E, Donina S, Sucker A, Hosen I, Egan KM, Barrett JH, van Doorn R, Bishop DT, Newton-Bishop J.

Pigment Cell Melanoma Res. 2014 Mar;27(2):234-43. doi: 10.1111/pcmr.12193. Epub 2013 Dec 11.

32.

Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer.

Nichols HB, Trentham-Dietz A, Newcomb PA, Egan KM, Titus LJ, Hampton JM, Visvanathan K.

Breast Cancer Res. 2013;15(5):R99.

33.

Circadian pathway genes in relation to glioma risk and outcome.

Madden MH, Anic GM, Thompson RC, Nabors LB, Olson JJ, Browning JE, Monteiro AN, Egan KM.

Cancer Causes Control. 2014 Jan;25(1):25-32. doi: 10.1007/s10552-013-0305-y. Epub 2013 Oct 18.

34.

Toenail iron, genetic determinants of iron status, and the risk of glioma.

Anic GM, Madden MH, Thompson RC, Nabors LB, Olson JJ, Larocca RV, Browning JE, Brockman JD, Forsyth PA, Egan KM.

Cancer Causes Control. 2013 Dec;24(12):2051-8. doi: 10.1007/s10552-013-0281-2. Epub 2013 Aug 31.

35.

Early life exposures and the risk of adult glioma.

Anic GM, Madden MH, Sincich K, Thompson RC, Nabors LB, Olson JJ, LaRocca RV, Browning JE, Pan E, Egan KM.

Eur J Epidemiol. 2013 Sep;28(9):753-8. doi: 10.1007/s10654-013-9811-1. Epub 2013 May 17.

36.

Prediagnostic body weight and survival in high grade glioma.

Siegel EM, Nabors LB, Thompson RC, Olson JJ, Browning JE, Madden MH, Han G, Egan KM.

J Neurooncol. 2013 Aug;114(1):79-84. doi: 10.1007/s11060-013-1150-2. Epub 2013 May 11.

37.

Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes.

Newcomb PA, Kampman E, Trentham-Dietz A, Egan KM, Titus LJ, Baron JA, Hampton JM, Passarelli MN, Willett WC.

J Clin Oncol. 2013 Jun 1;31(16):1939-46. doi: 10.1200/JCO.2012.46.5765. Epub 2013 Apr 8.

38.

Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression.

Park JY, Amankwah EK, Anic GM, Lin HY, Walls B, Park H, Krebs K, Madden M, Maddox K, Marzban S, Fang S, Chen W, Lee JE, Wei Q, Amos CI, Messina JL, Sondak VK, Sellers TA, Egan KM.

Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):827-34. doi: 10.1158/1055-9965.EPI-12-1129. Epub 2013 Mar 5.

39.

Anthropometric factors in relation to risk of glioma.

Little RB, Madden MH, Thompson RC, Olson JJ, Larocca RV, Pan E, Browning JE, Egan KM, Nabors LB.

Cancer Causes Control. 2013 May;24(5):1025-31. doi: 10.1007/s10552-013-0178-0. Epub 2013 Mar 3.

40.

Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.

Andersen SW, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA.

Menopause. 2013 Mar;20(3):354-8. doi: 10.1097/GME.0b013e318268ca46.

41.

SWI/SNF gene variants and glioma risk and outcome.

Amankwah EK, Thompson RC, Nabors LB, Olson JJ, Browning JE, Madden MH, Egan KM.

Cancer Epidemiol. 2013 Apr;37(2):162-5. doi: 10.1016/j.canep.2012.12.001. Epub 2012 Dec 29.

42.

Rare and uncommon genetic variants may hold key to the 'missing heritability' in glioma.

Egan KM, Wrensch MR, Jenkins RB.

CNS Oncol. 2012 Nov;1(2):109-12. doi: 10.2217/cns.12.19. No abstract available.

43.

Postoophorectomy estrogen use and breast cancer risk.

Nichols HB, Trentham-Dietz A, Newcomb PA, Titus LJ, Egan KM, Hampton JM, Visvanathan K.

Obstet Gynecol. 2012 Jul;120(1):27-36.

44.

Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).

Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks A, Hogervorst FB, Bueno-de-Mesquita HB, Muir KR, Lophatananon A, Rattanamongkongul S, Puttawibul P, Fasching PA, Hein A, Ekici AB, Beckmann MW, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Sawyer E, Tomlinson I, Kerin M, Miller N, Marmee F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Cordina-Duverger E, Menegaux F, Truong T, Bojesen SE, Nordestgaard BG, Flyger H, Milne RL, Perez JI, Zamora MP, Benítez J, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, Müller H, Arndt V, Stegmaier C, Rahman N, Seal S, Turnbull C, Renwick A, Meindl A, Schott S, Bartram CR, Schmutzler RK, Brauch H, Hamann U, Ko YD; GENICA Network, Wang-Gohrke S, Dörk T, Schürmann P, Karstens JH, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova NV, Zalutsky IV, Antonenkova NN, Bermisheva M, Prokovieva D, Farahtdinova A, Khusnutdinova E, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen J, Chen X, Beesley J; Kconfab Investigators; AOCS Group, Lambrechts D, Zhao H, Neven P, Wildiers H, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Manoukian S, Barile M, Couch FJ, Olson JE, Wang X, Fredericksen Z, Giles GG, Baglietto L, McLean CA, Severi G, Offit K, Robson M, Gaudet MM, Vijai J, Alnæs GG, Kristensen V, Børresen-Dale AL, John EM, Miron A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Figueroa JD, García-Closas M, Lissowska J, Sherman ME, Hooning M, Martens JW, Seynaeve C, Collée M, Hall P, Humpreys K, Czene K, Liu J, Cox A, Brock IW, Cross SS, Reed MW, Ahmed S, Ghoussaini M, Pharoah PD, Kang D, Yoo KY, Noh DY, Jakubowska A, Jaworska K, Durda K, Złowocka E, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Shen CY, Yu JC, Hsu HM, Hou MF, Orr N, Schoemaker M, Ashworth A, Swerdlow A, Trentham-Dietz A, Newcomb PA, Titus L, Egan KM, Chenevix-Trench G, Antoniou AC, Humphreys MK, Morrison J, Chang-Claude J, Easton DF, Dunning AM.

PLoS One. 2012;7(8):e42380. Epub 2012 Aug 7. Erratum in: PLoS One. 2012;7(10). doi:10.1371/annotation/e5de602c-0ffc-4e6f-a2ed-f79913c2e57c. Bueno-de-Mesquit, H Bas [corrected to Bueno-de-Mesquita, H Bas].

45.

A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24.

Higginbotham KS, Breyer JP, McReynolds KM, Bradley KM, Schuyler PA, Plummer WD, Freudenthal ME, Trentham-Dietz A, Newcomb PA, Parl FF, Sanders ME, Page DL, Egan KM, Dupont WD, Smith JR.

Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1565-73. doi: 10.1158/1055-9965.EPI-12-0386. Epub 2012 Jul 17.

46.

An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome.

Anic GM, Thompson RC, Nabors LB, Olson JJ, Browning JE, Madden MH, Murtagh FR, Forsyth PA, Egan KM.

Cancer Causes Control. 2012 Sep;23(9):1443-9. doi: 10.1007/s10552-012-0018-7. Epub 2012 Jun 28. Erratum in: Cancer Causes Control. 2012 Oct;23(10):1745. Burton Nabors, L [corrected to Nabors, L Burton]; Reed Murtagh, F [corrected to Murtagh, F Reed].

47.

Rare TP53 genetic variant associated with glioma risk and outcome.

Egan KM, Nabors LB, Olson JJ, Monteiro AN, Browning JE, Madden MH, Thompson RC.

J Med Genet. 2012 Jul;49(7):420-1. doi: 10.1136/jmedgenet-2012-100941. Epub 2012 Jun 15.

48.

Metformin- A Promising Agent for Chemoprevention in BRCA1 Carriers.

Kumar NB, Vadaparampil ST, Mahajan N, Lilienfeld HS, Lee JH, Laronga C, Hakam A, Hein JJ, Egan KM, Arun B, Pal T.

Hereditary Genet. 2012 Jun;1(2). pii: 104. No abstract available.

49.

Osseous and meningeal involvement in secondary syphilis.

Egan KM, Walters MC.

Dermatol Online J. 2012 Apr 15;18(4):1.

50.

Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis.

Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, Baird DM, Prescott J, De Vivo I, Nitti D.

J Natl Cancer Inst. 2012 Jun 6;104(11):840-54. doi: 10.1093/jnci/djs222. Epub 2012 Apr 20. Review.

Supplemental Content

Support Center